Skip to main content
OpenTrials

Clinical trial condition

Thalassemia

Explore clinical trials studying Thalassemia. Study availability and eligibility vary by location and protocol.

170 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Thalassemia trial results

Enrolling by invitation

Open-Label Extension Study to Pioneer Study 6058-SCD-101

NCT07401823

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Our Lady of the Lake Hospital Baton Rouge, Louisiana, United States
  • Boston Medical Center Boston, Massachusetts, United States
View Trial Details
Enrolling by invitation

The BENeFiTS Trial in Beta Thalassemia Intermedia

NCT04432623

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • UCSF Benioff Children's Hospital at Oakland Oakland, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Susan Perrine Weston, Massachusetts, United States
  • Weil Cornell Medicine New York, United States
View Trial Details
Enrolling by invitation

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

NCT06363760

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Smilow Cancer Hospital New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View all 18 locations
View Trial Details
Active, not recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT05664737

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Local Institution - 0011 Haikou, Hainan, China
  • Local Institution - 0012 Kunming, Yunnan, China
  • Local Institution - 0018 Rio, G, Greece
  • Local Institution - 0006 Athens, Greece
View all 31 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Local Institution - 0002 Ahmedabad, Gujarat, India
  • Local Institution - 0001 New Delhi, National Capital Territory of Delhi, India
  • Local Institution - 0007 Kolkata, West Bengal, India
  • Local Institution - 0005 Assam, India
View Trial Details
Active, not recruiting

A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)

NCT05353647

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • UC Davis Medical Center Sacramento, California, United States
View Trial Details
Active, not recruiting

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

NCT05577312

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit Guanzhou, Guangdong, China
  • Shenzhen Children 's Hospital Shenzhen, Guangdong, China
  • No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital Nanning, Guangxi, China
View Trial Details

Related conditions